Anhui Anke Biotechnology (Group)Co.,Ltd.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Anhui Anke Biotechnology (Group) Co., Ltd. is a high-tech enterprise mainly engaged in the research and development, production, and sales of biopharmaceuticals, and one of the first listed companies on the China Growth Enterprise Market. It has been recognized as a national innovative (pilot) enterprise, a national technological innovation demonstration enterprise, and one of the top 100 comprehensive manufacturing enterprises in Anhui Province. It is a leading biopharmaceutical enterprise in Anhui Province, with technology platforms such as a nationally recognized enterprise technology center, a national and local joint engineering research center for tumor precision treatment technology and products, an Anhui Provincial Biotechnology Laboratory, a key laboratory for genetic engineering pharmaceuticals in Anhui Province, and an Anhui Provincial Innovation Center for Tumor Precision Treatment Products. The company's existing products and services cover various fields such as biological products, modern Chinese medicine, chemical and small molecule drugs, peptide drugs, in vitro diagnostic reagents, forensic testing, targeted anti-tumor drugs, cellular immunotherapy, and so on. Nearly 20 subsidiaries, including Anke Yu Liangqing, Anke Hengyi, Shanghai Suhao Yiming, Wuxi Zhongde Meilian, and Xinhuakun, are located in Anhui, Shanghai, Jiangsu, Zhejiang, Guangdong, and other regions. The company has undertaken dozens of national "863" plan, national science and technology breakthrough plan, national key torch plan, national major new drug creation and provincial-level science and technology breakthrough projects, independently researched and developed more than 10 national level new drugs, and has won two National Science and Technology Progress Second Prizes, one National Science and Technology Progress Third Prizes, one National Patent Excellence Award, three Anhui Province Science and Technology Progress First Prizes, and two Anhui Province Science and Technology Progress Second Prizes There are numerous honors such as 2 third prizes for scientific and technological progress in Anhui Province, 2 outstanding contribution awards from the provincial government, 1 major scientific and technological achievement award in Anhui Province, and 2 patent gold awards in Anhui Province. In the future, the company will always adhere to the corporate philosophy of "interpreting life through technology, and achieving health through love", focusing on the main business of biopharmaceuticals. Based on existing products, the company will aim to develop cutting-edge technologies in the development of biopharmaceuticals such as gene editing, cell immunotherapy, and oncolytic virus therapy, continuously enhancing its influence in the pharmaceutical industry with high-quality products and services, and achieving high-quality and sustainable development of the company. |
| Headquarter | Hefei |
| Establish Date | 9/28/2000 |
| Listed Code | 300009.SZ |
| Listed Date | 10/30/2009 |
| Chairman | Song Lihua. |
| CEO | Song Lihua. |
| Website | www.ankebio.com |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
